Free Trial
NASDAQ:ZIMV

ZimVie (ZIMV) Stock Price, News & Analysis

ZimVie logo
$12.00 -0.55 (-4.38%)
Closing price 04:00 PM Eastern
Extended Trading
$11.99 -0.01 (-0.08%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ZimVie Stock (NASDAQ:ZIMV)

Key Stats

Today's Range
$11.91
$12.48
50-Day Range
$12.55
$14.99
52-Week Range
$11.91
$22.40
Volume
234,576 shs
Average Volume
119,233 shs
Market Capitalization
$332.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00
Consensus Rating
Buy

Company Overview

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Remove Ads

ZimVie Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

ZIMV MarketRank™: 

ZimVie scored higher than 44% of companies evaluated by MarketBeat, and ranked 593rd out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ZimVie has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ZimVie has only been the subject of 1 research reports in the past 90 days.

  • Read more about ZimVie's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ZimVie is -0.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ZimVie is -0.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ZimVie has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about ZimVie's valuation and earnings.
  • Percentage of Shares Shorted

    1.28% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently decreased by 4.68%, indicating that investor sentiment is improving.
  • Dividend Yield

    ZimVie does not currently pay a dividend.

  • Dividend Growth

    ZimVie does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.28% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently decreased by 4.68%, indicating that investor sentiment is improving.
  • Search Interest

    Only 1 people have searched for ZIMV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ZimVie insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.01% of the stock of ZimVie is held by insiders.

  • Percentage Held by Institutions

    95.63% of the stock of ZimVie is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ZimVie's insider trading history.
Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

ZIMV Stock News Headlines

Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… They’re studying something far more alien… Something you’ve never seen before…
Q4 2024 ZimVie Inc Earnings Call
ZimVie: Making Some Progress
ZimVie reports Q4 adjusted EPS 27c, consensus 26c
See More Headlines

ZIMV Stock Analysis - Frequently Asked Questions

ZimVie's stock was trading at $13.95 at the beginning of the year. Since then, ZIMV shares have decreased by 14.0% and is now trading at $12.00.
View the best growth stocks for 2025 here
.

ZimVie Inc. (NASDAQ:ZIMV) released its earnings results on Wednesday, February, 26th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.02. The company had revenue of $111.52 million for the quarter, compared to analysts' expectations of $113.67 million. ZimVie had a negative net margin of 77.31% and a positive trailing twelve-month return on equity of 2.90%.

Top institutional investors of ZimVie include Vanguard Group Inc. (6.47%), J. Goldman & Co LP (5.17%), Neuberger Berman Group LLC (4.75%) and Dimensional Fund Advisors LP (4.51%). Insiders that own company stock include Camber Capital Management Lp, Vafa Jamali and Richard Heppenstall.
View institutional ownership trends
.

Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZimVie investors own include Chevron (CVX), Comcast (CMCSA), Bristol-Myers Squibb (BMY), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

Last Earnings
2/26/2025
Today
3/10/2025
Next Earnings (Estimated)
5/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ZIMV
Fax
N/A
Employees
2,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.00
High Stock Price Target
$23.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+91.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
20.00
P/E Growth
N/A
Net Income
$-393,280,000.00
Pretax Margin
-8.39%

Debt

Sales & Book Value

Annual Sales
$449.75 million
Cash Flow
$4.33 per share
Price / Cash Flow
2.77
Book Value
$15.43 per share
Price / Book
0.78

Miscellaneous

Free Float
26,768,000
Market Cap
$332.12 million
Optionable
Optionable
Beta
2.10
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:ZIMV) was last updated on 3/10/2025 by MarketBeat.com Staff
From Our Partners